Janus Henderson Group PLC Shattuck Labs, Inc. Transaction History

Janus Henderson Group PLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 16, 2021	SELL	$17.57 - $28.95 $10.5 Million - $17.4 Million	-600,212 Closed	0 $0
Q2 2021 Aug 16, 2021	SELL	$24.14 - $37.68 $20.9 Million - $32.6 Million	-865,869 Reduced 59.06%	600,212 $17.4 Million
Q1 2021 May 17, 2021	SELL	$27.92 - $52.5 $4.91 Million - $9.24 Million	-176,029 Reduced 10.72%	1,466,081 $41 Million
Q4 2020 Feb 16, 2021	BUY	$19.0 - $57.61 $31.2 Million - $94.6 Million	1,642,110 New	1,642,110 $79.2 Million

28.8M

300

1.2K

Ticker STTK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 42,382,000
Market Cap $47M
Description
Shattuck Labs, Inc., a clinical-stage biotechnology company, develops therapeutics for the treatment of cancer and autoimmune disease in the United States. The company's lead product candidate is SL-172154, which is in Phase 1 clinical trial for the treatment of ovarian, fallopian tube, and peritoneal cancers. It also develops SL-279252 that is ...

Get notified when there are updates to the investment portfolio of Janus Henderson Group PLC, based on Form 13F filings with the SEC.

Stay updated on Janus Henderson Group PLC with notifications on news.